Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis

Abstract Background ACE1 I/D rs1799752 and ACE2 rs2285666 genetic polymorphisms could play a critical role in altering the clinical outcomes of SARS‐CoV‐2. The findings of previous studies remained inconclusive. This meta‐analysis was performed to evaluate the association and provide a more reliable...

Full description

Bibliographic Details
Main Authors: Md. Abdul Aziz, Mohammad Safiqul Islam
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.2063
_version_ 1798015431693303808
author Md. Abdul Aziz
Mohammad Safiqul Islam
author_facet Md. Abdul Aziz
Mohammad Safiqul Islam
author_sort Md. Abdul Aziz
collection DOAJ
description Abstract Background ACE1 I/D rs1799752 and ACE2 rs2285666 genetic polymorphisms could play a critical role in altering the clinical outcomes of SARS‐CoV‐2. The findings of previous studies remained inconclusive. This meta‐analysis was performed to evaluate the association and provide a more reliable outcome. Methods This study was completed following the updated recommendations of PRISMA using RevMan 5.4.1 statistical software. Results A total of 11 studies with 950 severe cases and 1573 non‐severe cases with COVID‐19 infection were included. Pooled analysis showed that ACE1 I/D polymorphism was correlated with the severity of SARS‐CoV‐2 in the DD genotype and D allele for the fixed‐effects model (OR:1.27 and OR:1.17). Besides, codominant 3, recessive, and allele models were associated with the severity of the fixed‐effects model (OR:1.35, OR:1.37, and OR:1.20) in Caucasian ethnicity. ACE2 rs2285666 was linked with the severity in codominant 3 (OR:2.63, for both random‐ and fixed effects‐models), overdominant (OR:1.97, for random‐effects model and OR:1.97, for fixed effects‐model), and recessive model (OR:0.41 for fixed‐ and random‐effects model). Allele model of rs2285666 showed a significant association in the fixed‐effects model (OR:1.61). Conclusion Our present meta‐analysis suggests that ACE1 I/D rs1799752 and ACE2 rs2285666 variants may enhance the severity in SARS‐CoV‐2 infected patients. Future studies are warranted to verify our findings.
first_indexed 2024-04-11T15:34:23Z
format Article
id doaj.art-3e67fa51e5ae4b989c31ccd4ce8ee56f
institution Directory Open Access Journal
issn 2324-9269
language English
last_indexed 2024-04-11T15:34:23Z
publishDate 2022-11-01
publisher Wiley
record_format Article
series Molecular Genetics & Genomic Medicine
spelling doaj.art-3e67fa51e5ae4b989c31ccd4ce8ee56f2022-12-22T04:16:03ZengWileyMolecular Genetics & Genomic Medicine2324-92692022-11-011011n/an/a10.1002/mgg3.2063Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysisMd. Abdul Aziz0Mohammad Safiqul Islam1Department of Pharmacy, Faculty of Pharmacy and Health Sciences State University of Bangladesh Dhaka BangladeshLaboratory of Pharmacogenomics and Molecular Biology, Department of Pharmacy Noakhali Science and Technology University Sonapur BangladeshAbstract Background ACE1 I/D rs1799752 and ACE2 rs2285666 genetic polymorphisms could play a critical role in altering the clinical outcomes of SARS‐CoV‐2. The findings of previous studies remained inconclusive. This meta‐analysis was performed to evaluate the association and provide a more reliable outcome. Methods This study was completed following the updated recommendations of PRISMA using RevMan 5.4.1 statistical software. Results A total of 11 studies with 950 severe cases and 1573 non‐severe cases with COVID‐19 infection were included. Pooled analysis showed that ACE1 I/D polymorphism was correlated with the severity of SARS‐CoV‐2 in the DD genotype and D allele for the fixed‐effects model (OR:1.27 and OR:1.17). Besides, codominant 3, recessive, and allele models were associated with the severity of the fixed‐effects model (OR:1.35, OR:1.37, and OR:1.20) in Caucasian ethnicity. ACE2 rs2285666 was linked with the severity in codominant 3 (OR:2.63, for both random‐ and fixed effects‐models), overdominant (OR:1.97, for random‐effects model and OR:1.97, for fixed effects‐model), and recessive model (OR:0.41 for fixed‐ and random‐effects model). Allele model of rs2285666 showed a significant association in the fixed‐effects model (OR:1.61). Conclusion Our present meta‐analysis suggests that ACE1 I/D rs1799752 and ACE2 rs2285666 variants may enhance the severity in SARS‐CoV‐2 infected patients. Future studies are warranted to verify our findings.https://doi.org/10.1002/mgg3.2063ACE1ACE2COVID‐19meta‐analysisSARS‐CoV‐2
spellingShingle Md. Abdul Aziz
Mohammad Safiqul Islam
Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
Molecular Genetics & Genomic Medicine
ACE1
ACE2
COVID‐19
meta‐analysis
SARS‐CoV‐2
title Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
title_full Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
title_fullStr Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
title_full_unstemmed Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
title_short Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
title_sort association of ace1 i d rs1799752 and ace2 rs2285666 polymorphisms with the infection and severity of covid 19 a meta analysis
topic ACE1
ACE2
COVID‐19
meta‐analysis
SARS‐CoV‐2
url https://doi.org/10.1002/mgg3.2063
work_keys_str_mv AT mdabdulaziz associationoface1idrs1799752andace2rs2285666polymorphismswiththeinfectionandseverityofcovid19ametaanalysis
AT mohammadsafiqulislam associationoface1idrs1799752andace2rs2285666polymorphismswiththeinfectionandseverityofcovid19ametaanalysis